Prometeus Labs

Prometheus Laboratories functions as a specialized clinical diagnostics company focused on improving patient outcomes in gastroenterology. It delivers a comprehensive portfolio of advanced diagnostic tests, primarily targeting Inflammatory Bowel Disease (IBD) and other gastrointestinal conditions. The company offers precision-guided solutions for disease interception, optimized therapy selection, and therapeutic drug monitoring via its PredictrPK and Anser test suites.

Jonathan Braun and Scott Glenn co-founded Prometheus Laboratories Inc., addressing significant diagnostic gaps in gastroenterological care. While precise founding details and the specific catalytic insight remain largely undocumented, this foundational focus on understanding and managing complex GI disorders has consistently driven its clinical innovation.

The company primarily serves healthcare providers managing patients through all stages of gastrointestinal diseases. Prometheus Laboratories' vision is to empower clinicians with actionable diagnostic results, enabling confident, informed decisions for patient care. It aims to enhance patient journeys and improve therapeutic interventions in digestive health with guiding diagnostic tools.